AURO LABORATORIES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Auro Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
3.91₹ 7.3
As on Oct 31, 2025, 4:01 PM IST
Auro Laboratories Price Performance
Today's LowToday's High
₹190.00₹194.95
₹193.95
52 Weeks' Low52 Weeks' High
₹170.00₹303.00
₹193.95
Open Price
₹194.95
Prev. Close
₹186.65
Volume
12,093
Over the last 5 years, the share price of Auro Laboratories has gained 19.89% CAGR. Over the past year, the corresponding return has been -22.28%.
Auro Laboratories’s current P/E of 173.32x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Auro Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Auro Laboratories | -10.23 | -18.59 | -29.18 | -21.25 | -23.6 | 36.33 | 19.89 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | 3.73 | -7.6 | -9.08 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 6.34 | 10.85 | 14.59 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | 0.03 | -1.58 | -3.69 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.8 | -0.38 | -3.39 | 9.01 | 10.66 | 29.1 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -1.68 | 1.37 | -4.72 | 10.6 | 4.3 |
| Mankind Pharma | -2.15 | -2.43 | -7.14 | -0.11 | -11.57 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 2.64 | 10 | -2.99 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 5.56 | -4.31 | -10.42 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | 5.46 | -6.06 | -18.73 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 12.48 | 8.53 | -5.2 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -13.89 | -5.7 | -1.05 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -8.54 | 37.43 | 11.8 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 12.55 | 53.86 | 91.09 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -2.86 | 16.74 | 17.02 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -10.55 | -8 | -3.86 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -3.73 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -12.53 | -7.87 | -21.04 | 11.98 | 2 |
| Gland Pharma | -0.6 | -2.66 | -2.59 | 37.25 | 17.21 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -8.44 | -4.54 | -19.88 | 23.86 | 18.63 |
Over the last one year, Auro Laboratories has declined 23.60% compared to peers like Sun Pharmaceutical Industries (-9.08%), Divi's Laboratories (14.59%), Cipla (-3.69%). From a 5 year perspective, Auro Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Auro Laboratories Financials
Auro Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 211.56 | 199.72 |
| 10 | 215.49 | 206.95 |
| 20 | 220.72 | 214.88 |
| 50 | 230.82 | 228.25 |
| 100 | 250.1 | 237.96 |
| 200 | 245.27 | 238.07 |
Auro Laboratories Share Holding Pattern
In the latest quarter, Auro Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.01%, FII holding unchanged at 0.00%, and public shareholding unchanged at 47.82% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Auro Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 14, 2025, 2:39 AM IST | Auro Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 30, 2025, 12:49 AM IST | Auro Labs - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 26, 2025, 12:56 AM IST | Auro Labs - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Sep 04, 2025, 12:23 AM IST | Auro Labs - Regulation 36(1)(B) Of SEBI (LODR) Regulations |
| Sep 03, 2025, 7:44 PM IST | Auro Labs - Reg. 34 (1) Annual Report. |
About Auro Laboratories
Auro Laboratories Ltd. is a Public Limited Listed company incorporated on 26/05/1989 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L33125MH1989PLC051910 and registration number is 051910. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 19.40 Cr. and Equity Capital is Rs. 6.23 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressK-56, M.I.D.C. Industrial Area, Palghar District Maharashtra 401506
- Contact
Management
- Mr. Sharat DeorahChairman & Managing Director
- Mr. Kiran Suresh KulkarniWhole Time Director
- Mr. Siddhartha DeorahWhole Time Director
- Mr. Mahendra Kumar DagaInd. Non-Executive Director
- Mrs. Kavita Vijayakant SharmaInd. Non-Executive Director
- Mr. Vishal Kailashchandra JhunjhunwalaInd. Non-Executive Director
FAQs on Auro Laboratories Share Price
What is the share price of Auro Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Auro Laboratories is ₹193.95 as on Oct 31, 2025.
What kind of stock is Auro Laboratories?
The Auro Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Auro Laboratories?
The market cap of Auro Laboratories is ₹120.88 Cr as on Oct 31, 2025.
What are today's High and Low prices of Auro Laboratories?
Today’s highest and lowest price of Auro Laboratories are ₹194.95 and ₹190.00.
What are the 52 Week High and 52 Week Low of Auro Laboratories?
The 52-week high/low is the highest and lowest price at which Auro Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Auro Laboratories is ₹303.00 and 52-week low of Auro Laboratories is ₹170.00 as on Oct 31, 2025.
How has the Auro Laboratories performed historically in terms of returns?
The Auro Laboratories has shown returns of 3.91% over the past day, -18.59% for the past month, -29.32% over 3 months, -22.28% over 1 year, 36.33% across 3 years, and 19.89% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Auro Laboratories?
P/E ratio of and PB ratio of Auro Laboratories are 173.32 and 2.81 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse